Park Avenue Securities’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,293
| Closed | -$526K | – | 1563 |
|
|
2024
Q4 | $526K | Buy |
6,293
+1,103
| +21% | +$92.2K | 0.01% | 1046 |
|
|
2024
Q3 | $380K | Sell |
5,190
-685
| -12% | -$50.2K | ﹤0.01% | 1089 |
|
|
2024
Q2 | $402K | Buy |
5,875
+318
| +6% | +$21.8K | ﹤0.01% | 1061 |
|
|
2024
Q1 | $385K | Sell |
5,557
-25
| -0.4% | -$1.73K | 0.01% | 1073 |
|
|
2023
Q4 | $400K | Buy |
5,582
+37
| +0.7% | +$2.65K | 0.01% | 1005 |
|
|
2023
Q3 | $289K | Buy |
+5,545
| New | +$289K | ﹤0.01% | 1066 |
|
|
2023
Q1 | – | Sell |
-4,838
| Closed | -$256K | – | 1193 |
|
|
2022
Q4 | $256K | Sell |
4,838
-260
| -5% | -$13.8K | ﹤0.01% | 1048 |
|
|
2022
Q3 | $237K | Buy |
+5,098
| New | +$237K | ﹤0.01% | 1005 |
|